Ascending Single Dose Study Of The Safety, Tolerability And Pharmacokinetics Of SAM-760 Administered Orally To Healthy Young And Healthy Elderly Subjects.

Trial Profile

Ascending Single Dose Study Of The Safety, Tolerability And Pharmacokinetics Of SAM-760 Administered Orally To Healthy Young And Healthy Elderly Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 22 Feb 2013

At a glance

  • Drugs PF 5212377 (Primary) ; Ketoconazole
  • Indications Alzheimer's disease
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 21 Feb 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 21 Feb 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Jul 2011 Results presented at the 2011 International Conference on Alzheimer's Disease.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top